Register entry
- Registered sites
- 22
- Active NDC listings
- 259
- Labeller names
- 2
- Live patents
- 0
- Countries
- 6
- Base
- United States
Authorisation
Registered operations
Analytical testing20Active ingredient (API) manufacture2Labelling8Finished drug manufacture17Packaging12particle size reduction2Relabelling1Repackaging1
Sites
Registered establishments
22| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| CATALENT ARGENTINA S.A.I.C.Registrant: Catalent Pharma Solutions Inc. | Avenida Bernabe Marquez 691, Villa Loma Hermosa, Buenos Aires, - 1657, Argentina (ARG) | Analytical testing, Finished drug manufacture | 3004258511970545174 |
| Catalent Ontario LimitedRegistrant: Catalent Pharma Solutions Inc. | 720 Wright St, Strathroy, Ontario N7G 3H8, Canada (CAN) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3007325436243944050 |
| Catalent Ontario LimitedRegistrant: Catalent Pharma Solutions Inc. | 687 Adair Blvd, Strathroy, Ontario N7G 3H8, Canada (CAN) | Analytical testing, Finished drug manufacture, Packaging | 3048241818243357474 |
| Catalent Ontario LimitedRegistrant: Catalent Pharma Solutions Inc. | 2125 Ambassador Drive, Windsor, Ontario N9C 3R5, Canada (CAN) | Analytical testing, Finished drug manufacture | 3000118564248441727 |
| Catalent Germany Eberbach GmbHRegistrant: Catalent Pharma Solutions Inc. | Gammelsbacher Strasse 2, Eberbach, Baden 69412, Germany (DEU) | Analytical testing, Finished drug manufacture | 3002808098318612223 |
| Catalent Germany Schorndorf GmbHRegistrant: Catalent Pharma Solutions Inc. | Steinbeisstrasse 1-2, Schorndorf, - D-73614, Germany (DEU) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3003831171315732628 |
| Catalent France Beinheim SARegistrant: Catalent Pharma Solutions Inc. | 74 Rue Principale, Beinheim, - 67930, France (FRA) | Analytical testing, Finished drug manufacture | 3002808036276167087 |
| CATALENT FRANCE LIMOGES SASRegistrant: Catalent Pharma Solutions Inc. | 48 RUE GILLES DE ROBERVAL, LIMOGES, 87280, France (FRA) | Analytical testing, Finished drug manufacture | 3008191278571290167 |
| Catalent Micron Technologies LtdRegistrant: Catalent Pharma Solutions Inc. | Crossways Boulevard, Crossways, Dartford, Kent DA2 6QY, United Kingdom (GBR) | Analytical testing, particle size reduction | 3002807652226428217 |
| Catalent CTS (Edinburgh) LimitedRegistrant: Catalent Pharma Solutions Inc. | 1 Inchwood Park, Bathgate, Edinburgh, EH48 2FY, United Kingdom (GBR) | Labelling, Packaging | 3009442470233814990 |
| CATALENT U.K. SWINDON ZYDIS LIMITEDRegistrant: Catalent Pharma Solutions Inc. | Frankland Road, Blagrove, Swindon, Wiltshire SN5 8RU, United Kingdom (GBR) | Analytical testing, Finished drug manufacture, Packaging | 3003812585290022847 |
| Catalent Maryland, Inc.Registrant: Catalent Pharma Solutions Inc. | 801 West Baltimore St, Baltimore, Maryland (MD) 21201, United States (USA) | Analytical testing, Finished drug manufacture, Packaging | 3015558590618890289 |
| Catalent Massachusetts, LLCRegistrant: Catalent Pharma Solutions Inc. | 190 Everett Avenue, Chelsea, Massachusetts (MA) 02150-1817, United States (USA) | Analytical testing, Finished drug manufacture, Packaging | 3011696115117922533 |
| Catalent Greenville, Inc.Registrant: Catalent Pharma Solutions Inc. | 5440 MARTIN LUTHER KING JR BLVD, Greenville, North Carolina (NC) 27834, United States (USA) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3000209735118814439 |
| Catalent Maryland, Inc.Registrant: Catalent Pharma Solutions Inc. | 7555 Harmans Road, Harmans, Maryland (MD) 21077, United States (USA) | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3015434301116950534 |
| Catalent CTS, LLCRegistrant: Catalent Pharma Solutions Inc. | 10245 Hickman Mills Dr, Kansas City, Missouri (MO) 64137, United States (USA) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3002929455962674474 |
| Catalent Pharma Solutions, LLCRegistrant: Catalent Pharma Solutions Inc. | 726 Heartland Trl, Madison, Wisconsin (WI) 53717, United States (USA) | Analytical testing, Active ingredient (API) manufacture | 3010654212078726763 |
| Catalent Micron Technologies, Inc.Registrant: Catalent Pharma Solutions Inc. | 333 Phoenixville Pike, Malvern, Pennsylvania (PA) 19355, United States (USA) | Analytical testing, particle size reduction | 3007992266015966157 |
| Catalent Pharma Solutions, LLCRegistrant: Catalent Pharma Solutions Inc. | 160S Pharma Drive, Morrisville, North Carolina (NC) 27560, United States (USA) | Analytical testing, Finished drug manufacture | 1000110912119332987 |
| Catalent Pharma Solutions, LLCRegistrant: Catalent Pharma Solutions Inc. | 10381 Decatur Road, Philadelphia, Pennsylvania (PA) 19154, United States (USA) | Labelling, Packaging, Relabelling, Repackaging | 3007617094014904112 |
| Catalent Pharma Solutions, LLCRegistrant: Catalent Pharma Solutions Inc. | 2725 Scherer Drive North, St Petersburg, Florida (FL) 33716-1016, United States (USA) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 1811396119120716 |
| Catalent Pharma Solutions, LLCRegistrant: Catalent Pharma Solutions Inc. | 1100 Enterprise Drive, Winchester, Kentucky (KY) 40391, United States (USA) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 1000122400829672745 |
Catalogue
Drug listings by form and route
259259 active NDC listings: 259 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 231, EXPORT ONLY 28.
| Dosage form | NDCs |
|---|---|
| capsule | 109 |
| tablet, film coated | 32 |
| capsule, extended release | 31 |
| capsule, liquid filled | 31 |
| tablet | 19 |
| capsule, gelatin coated | 9 |
| insert | 5 |
| for suspension, extended release | 4 |
| lozenge | 4 |
| spray | 4 |
| powder | 3 |
| pellet | 2 |
| bead | 1 |
| capsule, delayed release | 1 |
| granule | 1 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| catalent pharma solutions, llc | 248 |
| catalent pharma solutions llc | 11 |
Catalogue
Marketed products
261Showing 150 of 261.
| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Acetaminophen | capsule | 11014-0353DRUG FOR FURTHER PROCESSING |
| - | Advil RF | capsule | 11014-0220DRUG FOR FURTHER PROCESSING |
| - | Amantadine | capsule | 11014-0234DRUG FOR FURTHER PROCESSING |
| - | Amantadine | capsule | 11014-0245DRUG FOR FURTHER PROCESSING |
| - | Apalutamide | tablet, film coated | 11014-0330DRUG FOR FURTHER PROCESSING |
| - | Apalutamide | tablet, film coated | 11014-0485DRUG FOR FURTHER PROCESSING |
| - | Apalutamide | tablet, film coated | 11014-0762EXPORT ONLY |
| - | Atazanavir | powder | 11014-0175DRUG FOR FURTHER PROCESSING |
| - | Avapritinib | tablet, film coated | 11014-0403DRUG FOR FURTHER PROCESSING |
| - | Avapritinib | tablet, film coated | 11014-0404DRUG FOR FURTHER PROCESSING |
| - | Avapritinib | tablet, film coated | 11014-0405DRUG FOR FURTHER PROCESSING |
| - | Berotralstat hydrochloride | capsule | 11014-0437DRUG FOR FURTHER PROCESSING |
| - | Berotralstat hydrochloride | capsule | 11014-0495DRUG FOR FURTHER PROCESSING |
| - | Calcifediol | capsule | 11014-0204DRUG FOR FURTHER PROCESSING |
| - | Calcifediol | capsule | 11014-0440EXPORT ONLY |
| - | Calcitriol | capsule, gelatin coated | 11014-0012DRUG FOR FURTHER PROCESSING |
| - | Calcitriol | capsule, gelatin coated | 11014-0013DRUG FOR FURTHER PROCESSING |
| - | Calcitriol | capsule | 11014-0021DRUG FOR FURTHER PROCESSING |
| - | Colestipol Hydrochloride | tablet | 11014-0125DRUG FOR FURTHER PROCESSING |
| - | Colestipol Hydrochloride | capsule | 11014-0126DRUG FOR FURTHER PROCESSING |
| - | Crinecerfont | capsule | 11014-0664DRUG FOR FURTHER PROCESSING |
| - | Crinecerfont | capsule | 11014-0665DRUG FOR FURTHER PROCESSING |
| - | Crinecerfont | capsule | 11014-0681DRUG FOR FURTHER PROCESSING |
| - | Cyclosporine | capsule | 11014-0579EXPORT ONLY |
| - | Cyclosporine | capsule | 11014-0581DRUG FOR FURTHER PROCESSING |
| - | Cysclosporine | capsule | 11014-0580EXPORT ONLY |
| - | DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE | capsule | 11014-0375DRUG FOR FURTHER PROCESSING |
| - | DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE | capsule | 11014-0376DRUG FOR FURTHER PROCESSING |
| - | DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE | capsule | 11014-0377DRUG FOR FURTHER PROCESSING |
| - | DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE | capsule | 11014-0378DRUG FOR FURTHER PROCESSING |
| - | DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE | capsule | 11014-0379DRUG FOR FURTHER PROCESSING |
| - | DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE | capsule | 11014-0380DRUG FOR FURTHER PROCESSING |
| - | DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE | capsule, extended release | 11014-0720DRUG FOR FURTHER PROCESSING |
| - | DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE | capsule, extended release | 11014-0721DRUG FOR FURTHER PROCESSING |
| - | DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE | capsule, extended release | 11014-0722DRUG FOR FURTHER PROCESSING |
| - | DOXERCALCIFEROL | capsule, liquid filled | 11014-0029DRUG FOR FURTHER PROCESSING |
| - | Dextroamphetamine Sulfate | capsule | 11014-0323DRUG FOR FURTHER PROCESSING |
| - | Dextroamphetamine Sulfate | capsule, extended release | 11014-0324DRUG FOR FURTHER PROCESSING |
| - | Dextromethophan HBR, Pseudoephedrine, Acetaminophen, Guaifenesin | capsule | 11014-0191DRUG FOR FURTHER PROCESSING |
| - | Dextromethorphan hydrobromide and Guaifenesin | capsule, gelatin coated | 11014-0024DRUG FOR FURTHER PROCESSING |
| - | Diazepam | spray | 11014-0399DRUG FOR FURTHER PROCESSING |
| - | Diazepam | spray | 11014-0400DRUG FOR FURTHER PROCESSING |
| - | Diazepam | spray | 11014-0401DRUG FOR FURTHER PROCESSING |
| - | Diclofenac | capsule | 11014-0494EXPORT ONLY |
| - | Dihpenhydramine Hydrochloride | capsule, liquid filled | 11014-0020DRUG FOR FURTHER PROCESSING |
| - | Diphenhydramine HCl | capsule, liquid filled | 11014-0025DRUG FOR FURTHER PROCESSING |
| - | Doxycycline | capsule, delayed release | 11014-0092DRUG FOR FURTHER PROCESSING |
| - | Dutasteride | capsule | 11014-0215DRUG FOR FURTHER PROCESSING |
| - | Dutasteride | capsule | 11014-0216DRUG FOR FURTHER PROCESSING |
| - | Dutasteride | capsule | 11014-0247DRUG FOR FURTHER PROCESSING |
| - | Dutasteride | capsule | 11014-0340DRUG FOR FURTHER PROCESSING |
| - | Dutasteride | capsule | 11014-0392EXPORT ONLY |
| - | Dutateride Alopecia 0.1mg | capsule | 11014-0219DRUG FOR FURTHER PROCESSING |
| - | ENCORAFENIB | capsule | 11014-0577DRUG FOR FURTHER PROCESSING |
| - | ENCORAFENIB | capsule | 11014-0582DRUG FOR FURTHER PROCESSING |
| - | ENTRECTINIB | capsule | 11014-0562DRUG FOR FURTHER PROCESSING |
| - | ENTRECTINIB | capsule | 11014-0563DRUG FOR FURTHER PROCESSING |
| - | Elacestrant | tablet, film coated | 11014-0666DRUG FOR FURTHER PROCESSING |
| - | Elacestrant | tablet, film coated | 11014-0667DRUG FOR FURTHER PROCESSING |
| - | Encorafenib | capsule | 11014-0344DRUG FOR FURTHER PROCESSING |
| - | Encorafenib | capsule | 11014-0345DRUG FOR FURTHER PROCESSING |
| - | Ensitrelvir | tablet | 11014-0763DRUG FOR FURTHER PROCESSING |
| - | Entrectinib | capsule | 11014-0550DRUG FOR FURTHER PROCESSING |
| - | Entrectinib | capsule | 11014-0551DRUG FOR FURTHER PROCESSING |
| - | Ergocalciferol | capsule, liquid filled | 11014-0026DRUG FOR FURTHER PROCESSING |
| - | Ergocalciferol | capsule, liquid filled | 11014-0052DRUG FOR FURTHER PROCESSING |
| - | Esomeprazole Magnesium | capsule | 11014-0382DRUG FOR FURTHER PROCESSING |
| - | Esomeprazole Magnesium | pellet | 11014-0383DRUG FOR FURTHER PROCESSING |
| - | Esomeprazole Magnesium | capsule | 11014-0695DRUG FOR FURTHER PROCESSING |
| - | Esomeprazole Magnesium | capsule | 11014-0696DRUG FOR FURTHER PROCESSING |
| - | Esomeprazole Magnesium | pellet | 11014-0697DRUG FOR FURTHER PROCESSING |
| - | Estradiol and Norethindrone Acetate | capsule | 11014-0354DRUG FOR FURTHER PROCESSING |
| - | Estradiol and Progesterone | capsule | 11014-0339DRUG FOR FURTHER PROCESSING |
| - | Estradiol and Progesterone | capsule | 11014-0346DRUG FOR FURTHER PROCESSING |
| - | Ethosuximide | capsule | 11014-0047DRUG FOR FURTHER PROCESSING |
| - | Etripamil | spray | 11014-0766DRUG FOR FURTHER PROCESSING |
| - | Ferrous Fumarate | capsule | 11014-0202DRUG FOR FURTHER PROCESSING |
| - | Hydrocortisone | capsule | 11014-0765EXPORT ONLY |
| - | Ibrutinib | capsule | 11014-0163DRUG FOR FURTHER PROCESSING |
| - | Ibrutinib | tablet, film coated | 11014-0326DRUG FOR FURTHER PROCESSING |
| - | Ibrutinib | tablet, film coated | 11014-0327DRUG FOR FURTHER PROCESSING |
| - | Ibrutinib | tablet, film coated | 11014-0328DRUG FOR FURTHER PROCESSING |
| - | Ibrutinib | capsule | 11014-0417DRUG FOR FURTHER PROCESSING |
| - | Ibuprofen | capsule, liquid filled | 11014-0004DRUG FOR FURTHER PROCESSING |
| - | Ibuprofen | capsule | 11014-0429EXPORT ONLY |
| - | Ibuprofen/Diphenhydramine HCl | capsule | 11014-0427EXPORT ONLY |
| - | Icosapent Ethyl | capsule | 11014-0430DRUG FOR FURTHER PROCESSING |
| - | Icosapent Ethyl | capsule | 11014-0479DRUG FOR FURTHER PROCESSING |
| - | Icosapent Ethyl | capsule | 11014-0486DRUG FOR FURTHER PROCESSING |
| - | Icosapent Ethyl | capsule | 11014-0570DRUG FOR FURTHER PROCESSING |
| - | Lofexidine | tablet, film coated | 11014-0309DRUG FOR FURTHER PROCESSING |
| - | Loratadine | capsule, liquid filled | 11014-0031DRUG FOR FURTHER PROCESSING |
| - | Lunsotogene Parvec | injection, solution | 11014-0768DRUG FOR FURTHER PROCESSING |
| - | Methylphenidate Hydrochloride | capsule, extended release | 11014-0081DRUG FOR FURTHER PROCESSING |
| - | Methylphenidate Hydrochloride | capsule, extended release | 11014-0082DRUG FOR FURTHER PROCESSING |
| - | Methylphenidate Hydrochloride | capsule | 11014-0230DRUG FOR FURTHER PROCESSING |
| - | Methylphenidate Hydrochloride | capsule, extended release | 11014-0319DRUG FOR FURTHER PROCESSING |
| - | Methylphenidate Hydrochloride | capsule | 11014-0371DRUG FOR FURTHER PROCESSING |
| - | Miconazole Nitrate | insert | 11014-0045DRUG FOR FURTHER PROCESSING |
| - | Miconazole Nitrate | insert | 11014-0058DRUG FOR FURTHER PROCESSING |
| - | Miconazole Nitrate | suppository | 11014-0343DRUG FOR FURTHER PROCESSING |
| - | Miconazole Nitrate | capsule | 11014-0358DRUG FOR FURTHER PROCESSING |
| - | NIFEDIPINE | capsule | 11014-0038DRUG FOR FURTHER PROCESSING |
| - | Nicotine | lozenge | 11014-0742DRUG FOR FURTHER PROCESSING |
| - | Nicotine | lozenge | 11014-0743DRUG FOR FURTHER PROCESSING |
| - | Nicotine | lozenge | 11014-0744DRUG FOR FURTHER PROCESSING |
| - | Nicotine | lozenge | 11014-0745DRUG FOR FURTHER PROCESSING |
| - | Nifedipine | capsule, liquid filled | 11014-0035DRUG FOR FURTHER PROCESSING |
| - | Nifedipine | capsule, liquid filled | 11014-0036DRUG FOR FURTHER PROCESSING |
| - | Nifedipine | capsule | 11014-0341DRUG FOR FURTHER PROCESSING |
| - | Nifedipine | capsule | 11014-0342DRUG FOR FURTHER PROCESSING |
| - | Niraparib | tablet, film coated | 11014-0571DRUG FOR FURTHER PROCESSING |
| - | Niraparib | tablet, film coated | 11014-0572DRUG FOR FURTHER PROCESSING |
| - | Niraparib | tablet, film coated | 11014-0573DRUG FOR FURTHER PROCESSING |
| - | Opicapone | capsule | 11014-0421DRUG FOR FURTHER PROCESSING |
| - | PEXIDARTINIB | capsule | 11014-0394DRUG FOR FURTHER PROCESSING |
| - | PEXIDARTINIB | capsule | 11014-0481DRUG FOR FURTHER PROCESSING |
| - | Palonosetron Hydrochloride | capsule | 11014-0199DRUG FOR FURTHER PROCESSING |
| - | Paricalcitol | capsule, liquid filled | 11014-0336DRUG FOR FURTHER PROCESSING |
| - | Paricalcitol | capsule, liquid filled | 11014-0337DRUG FOR FURTHER PROCESSING |
| - | Pimavanserin tartrate | capsule | 11014-0420DRUG FOR FURTHER PROCESSING |
| - | Pirfenidone | capsule | 11014-0214DRUG FOR FURTHER PROCESSING |
| - | Pralsetinib | capsule | 11014-0740DRUG FOR FURTHER PROCESSING |
| - | Progesterone | capsule | 11014-0039DRUG FOR FURTHER PROCESSING |
| - | Progesterone | capsule, gelatin coated | 11014-0042DRUG FOR FURTHER PROCESSING |
| - | Progesterone | capsule | 11014-0043DRUG FOR FURTHER PROCESSING |
| - | Progesterone | capsule | 11014-0051DRUG FOR FURTHER PROCESSING |
| - | Progesterone | capsule | 11014-0189DRUG FOR FURTHER PROCESSING |
| - | Progesterone | capsule | 11014-0425EXPORT ONLY |
| - | Progestrone | capsule | 11014-0388EXPORT ONLY |
| - | Progestrone | capsule | 11014-0389EXPORT ONLY |
| - | Progestrone | capsule | 11014-0414EXPORT ONLY |
| - | Relacorilant | capsule | 11014-0711DRUG FOR FURTHER PROCESSING |
| - | Relacorilant | capsule | 11014-0734DRUG FOR FURTHER PROCESSING |
| - | Rhinadvil Cold and Sinus | capsule | 11014-0218DRUG FOR FURTHER PROCESSING |
| - | Roxadustat | tablet | 11014-0464EXPORT ONLY |
| - | Roxadustat | tablet | 11014-0465EXPORT ONLY |
| - | Roxadustat | tablet | 11014-0466EXPORT ONLY |
| - | Roxadustat | tablet | 11014-0467EXPORT ONLY |
| - | Roxadustat | tablet | 11014-0468EXPORT ONLY |
| - | SPARSENTAN | tablet, film coated | 11014-0483DRUG FOR FURTHER PROCESSING |
| - | SPARSENTAN | tablet, film coated | 11014-0484DRUG FOR FURTHER PROCESSING |
| - | Sebetralstat | tablet, film coated | 11014-0730DRUG FOR FURTHER PROCESSING |
| - | Selinexor | tablet, film coated | 11014-0393DRUG FOR FURTHER PROCESSING |
| - | Simethicone | capsule | 11014-0198DRUG FOR FURTHER PROCESSING |
| - | Suzetrigine | tablet, film coated | 11014-0728DRUG FOR FURTHER PROCESSING |
| - | Suzetrigine | tablet, film coated | 11014-0753DRUG FOR FURTHER PROCESSING |
| - | Tafamidis | capsule | 11014-0390DRUG FOR FURTHER PROCESSING |
| - | Tafamidis Meglumine | capsule | 11014-0207DRUG FOR FURTHER PROCESSING |
| - | Tecovirimat | capsule | 11014-0133DRUG FOR FURTHER PROCESSING |
Neighbours
Registered in the same town
12- Patheon Manufacturing Services LLCGreenville, NC; Swindon, GBR · 2 sites
- BioAgilytix Labs, LLCMorrisville, NC · 2 sites
- Biogen International GmbHMorrisville, NC · 2 sites
- Janssen Research & Development, L.L.C.Malvern, PA
- AstraZeneca PLCPhiladelphia, PA
- Charles River Laboratories, Inc.Malvern, PA
- Sigma-Aldrich CorporationMadison, WI
- SOFIE Co. dba SOFIEKansas City, MO
- Synergy Health AST, LLCSwindon, GBR
- Alcami Carolinas CorporationMorrisville, NC
- Exel Inc. dba DHL Supply Chain (USA)Morrisville, NC
- Ferring Pharmaceuticals Inc.Buenos Aires, ARG
Compare
Comparable companies in United States
- Merck & Co., Inc.23 sites · 0 NDC
- Janssen Research & Development, L.L.C.20 sites · 0 NDC
- Patheon Manufacturing Services LLC19 sites · 319 NDC
- Baxter Healthcare Corporation16 sites · 416 NDC
- AstraZeneca PLC15 sites · 153 NDC
- Lonza Biologics Inc15 sites · 80 NDC
- Oxarc LLC15 sites · 5 NDC
- Charles River Laboratories, Inc.15 sites · 0 NDC
- AbbVie Inc.13 sites · 131 NDC
- Sigma-Aldrich Corporation13 sites · 25 NDC
Enquiry
Common questions
- Is Catalent Pharma Solutions Inc. FDA approved?
- Catalent Pharma Solutions Inc. holds 22 FDA-registered establishments across 6 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Catalent Pharma Solutions Inc.'s drugs manufactured?
- At registered sites in Argentina, Canada, Germany, France, the United Kingdom, the United States. The FDA register lists Buenos Aires; Strathroy; Windsor; Eberbach; Schorndorf; Beinheim, and 15 more. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging, particle size reduction, relabelling, repackaging.
- What drugs does Catalent Pharma Solutions Inc. make?
- 261 products are listed under Catalent Pharma Solutions Inc. in the openFDA NDC Directory, most often as capsule; tablet, film coated; capsule, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.